drugset / Trial / NCT03601910

Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg

NCT03601910

Phase 1 Unknown 34 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

This study is an open-label, randomized, fasted, single-dose, 2-way crossover study to compare the pharmacokinetic characteristics and safety between CKD-380 10mg and D308 10mg in healthy male adults.

Timeline

Start
2018-07-16
Primary completion
2018-09-21
Completion
2018-11-09

Drugs

EvaluationDrugModalityDoseRoute
Subject D308 Unknown 10 mg Oral
Subject Dapagliflozin Small molecule 10 mg Oral